SRDX - Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday? | Benzinga
Private equity firm GTCR agreed to acquire medical device coating company Surmodics Inc (NASDAQ:SRDX) for approximately $627 million, or $43 per share.
The per-share acquisition price represents a 41.1% premium to Surmodics’ 30-trading day volume-weighted average closing price through May 28.
Surmodics’ board unanimously approved the cash deal. It also recommended ...